Ligand validation:4TM4

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 4TM4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TM4_FDA_D_501	74%	21%	0.134	0.964	2.09	1.39	16	7	0	0	100%	1
4TM4_FDA_A_501	73%	13%	0.141	0.97	2.18	1.94	19	13	4	0	100%	1
4TM4_FDA_B_501	71%	13%	0.141	0.963	2.12	2.01	17	14	3	0	100%	1
4TM4_FDA_C_501	65%	12%	0.156	0.958	2.19	2.06	18	14	0	0	100%	1
4TLX_FDA_D_501	85%	20%	0.101	0.965	2.14	1.41	17	8	0	0	100%	1
4TM1_FDA_A_501	78%	18%	0.128	0.972	2.21	1.47	18	9	2	0	100%	1
3TSH_FDA_A_601	100%	40%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
7AA2_FDA_A_701	100%	60%	0.043	0.986	0.69	0.83	-	1	3	0	100%	1
6ZE6_FDA_A_701	99%	60%	0.044	0.984	0.72	0.8	-	1	3	0	100%	1
4U2S_FDA_A_605	99%	16%	0.064	0.997	1.76	2.08	9	9	5	0	100%	1
6ZE2_FDA_B_701	99%	59%	0.048	0.979	0.71	0.83	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.